We Raised. Now Comes the Part That Matters Most: Putting the Money to Work

We Raised. Now Comes the Part That Matters Most: Putting the Money to Work

Putting Catalytic Capital to Work :

August and September have been nothing short of mind-blowing for us. Sawazisha MedTech Labs, an East African women’s health and femtech startup, has secured significant new grant funding to move two of our products forward: WarmEase, our menstrual pain relief product preparing for market entry, and WARIDI, our perineal protection medical device moving toward clinical trials focused on reducing perineal trauma during childbirth.

Answering Foundational Clinical Questions :

For us, this is more than a fundraising announcement. It gets us closer to answering questions we have carried for a long time: Can we reduce preventable childbirth injuries? Can we make menstrual pain relief more accessible? Can women’s health products be designed, tested, manufactured, and scaled from Africa? This funding gives us the opportunity to find out.

Building from Rwanda for Global Health :

We are building in parts of healthcare that have been underfunded and neglected for far too long: women’s health, maternal health, menstrual health, and postpartum recovery. And we are doing it from East Africa, in the land of a thousand hills, Rwanda. A special shoutout to our staunch supporters: Dr. Fred St. Goar, MD, the University of Global Health Equity (UGHE), and Prof. Rex Wong.

Clinical context

Building for women, with women, across the lifecycle.

Clinical Perspectives & Peer Discussion (2):

Dr. Marie-Chantal Uwamahoro, MD

Dr. Marie-Chantal Uwamahoro, MD

Oct 2026

Huge milestone for Sawazisha! Moving WARIDI into clinical trials in Rwanda sets a powerful precedent for African-born biodesign.

Sister Beatrice Otieno, Senior Midwife

Sister Beatrice Otieno, Senior Midwife

Oct 2026

WarmEase and Waridi are answering real needs we see on the ward every day. Onwards!

Leave a clinical perspective
Contributor